Eduardo Oliver, PhD
Researcher in Cardiovascular Pharmacology in Madrid, Spain
I am a MSCA Research Fellow in the Translational Laboratory for Cardiovascular Imaging and Therapy at the Spanish National Center for Cardiovascular Research (CNIC) in Madrid (Spain). My current research focuses on the study and better understanding of the mechanism of action of beta-blockers both at the cellular and molecular level, and its consequences at anatomical and physiological level in models of cardiovascular diseases.
I studied Pharmacy (2004) and completed my PhD in Pharmacology in 2010 at the University of Valencia (Spain). My thesis focused on the role of adrenergic receptors and GRKs in the genesis, maintenance and development of cardiovascular diseases such essential hypertension or terminal heart failure. I have overseas experience at the University of Rouen (France) during my degree, and at the University of Glasgow (Scotland, UK) during my PhD.
After my PhD, I moved to Imperial College London were I worked as a Research Associate within the Centre for Pharmacology & Therapeutics. During this time, I described the zinc transporter ZIP12 as a new potential drug target for the treatment of pulmonary hypertension, a serious heart and lung disease triggered by chronic hypoxia (Nature, 2015), thanks to this discoveries I published a patent, and was awarded in 2016 with the 'EPHAR Young Investigator Award'. The same year I was awarded with the 32nd Young Pharmacologist Award of the Spanish Society of Pharmacology.
Currently, I am an External Lecturer of the Master in Research and Rational Use of Medicines at the University of Valencia. Also, I am member of the Spanish Society of Pharmacology where I have been its first chair of the Young Pharmacologist committee ; and co-founder and Former President of SRUK/CERU.